Skip to main navigation Skip to search Skip to main content

HUC-MSC secretome and Nanoemulsion Propolis synergistically modulate inflammatory responses in hyperglycemia-induced calvarial osteolysis

  • Putri Cahaya Situmorang*
  • , Helen Helen
  • , Syafruddin Ilyas
  • , Salomo Hutahaean
  • , Doni Aldo Samuel Siahaan
  • , Ananto Ali Alhasyimi
  • , Muh Ade Artasasta
  • , Wibi Riawan
  • , Khairul Anuar Shariff
  • , Alexander Patera Nugraha
  • *Corresponding author for this work

Research output: Contribution to journal › Article › peer-review

Abstract

BackgroundHyperglycemia-induced osteolysis is a significant consequence of diabetes mellitus, marked by heightened inflammatory responses, augmented osteoclastogenesis, and compromised osteoblast function. Innovative therapy approaches aimed at inflammatory and cytoprotective mechanisms are essential to avert diabetic bone loss.ObjectiveThis study investigated the synergistic effects of human umbilical cord mesenchymal stem cell (HUC-MSC) secretome and Nanoemulsion Propolis (NEP) on inflammatory responses and protective protein expression in a rat model of hyperglycemia-associated calvarial osteolysis.MethodsMale Wistar rats were categorized into seven groups: control, LPS-induced inflammation, hyperglycemia, a combination of LPS and hyperglycemia, and treatment groups administered HUC-MSC secretome, NEP, or both. Cytokine concentrations (IL-1β, TNF-α, IL-10) were measured using ELISA, whilst NF-κB, IL-6, HSP-70, and HSP-10 expression in calvarial tissue was assessed by immunohistochemistry.ResultsLPS, in conjunction with hyperglycemia, significantly increased pro-inflammatory cytokines and NF-κB activation, reduced IL-10 levels, and inhibited HSP-70 and HSP-10, hence worsening bone resorption. Treatment with HUC-MSC secretome or NEP alone moderately diminished inflammation, however the combined therapy markedly downregulated NF-κB, IL-1β, TNF-α, and IL-6, while reinstating IL-10 and stress proteins. These modifications diminished osteoclast activation and maintained osteoblast viability, with the most significant protective impact noted in the combination group.ConclusionThe HUC-MSC secretome and NEP collaboratively influence inflammatory pathways and reinstate protective proteins in calvarial osteolysis triggered by hyperglycemia. This dual technique presents a promising acellular and natural product-based method for addressing diabetes bone loss and associated craniofacial problems.

Original languageEnglish
Article number101430
JournalJournal of Oral Biology and Craniofacial Research
Volume16
Issue number2
DOIs
Publication statusPublished - 1 Mar 2026

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Cytokines
  • HSP-70
  • HUC-MSC
  • Hyperglycemia
  • Inflammation
  • Osteolysis

Fingerprint

Dive into the research topics of 'HUC-MSC secretome and Nanoemulsion Propolis synergistically modulate inflammatory responses in hyperglycemia-induced calvarial osteolysis'. Together they form a unique fingerprint.

Cite this